ZAPetite is developing the first clincally-proven, natural appetite regulator that targets the brain to address the biological root cause of obesity.
With over 2.5 billion adults globally classified as overweight, many individuals are not eligible for effective but harsh pharmaceuticals. Instead, they are left navigating a supplement industry saturated with unproven and ineffective products.
ZAPetite offers a new path forward: a plant-based, over-the-counter oral capsule designed to regulate appetite at the neural level. Our preclinical studies, conducted at the University of Toronto, have demonstrated up to 15% weight loss, improved metabolic parameters, and no observed side effects. A first-in-human clinical trial is set to begin in January 2026.
Our vision is to empower individuals to take control of their weight loss journey with a solution that is accessible, science-driven, and trusted by consumers.
Company Details
- Employees
- 2
- Founded
- -
- Address
- 1 King's College Circle, Toronto,ontario M5s 1a8,canada
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.zapetite.com
- HQ
- Toronto, Ontario
Zapetite Inc Questions
Zapetite Inc's website is https://www.zapetite.com
Zapetite Inc's LinkedIn profile is https://ca.linkedin.com/company/zapetite-inc
Zapetite Inc has
2 employees.
View email and phone details for 2
employees at Zapetite Inc.
Zapetite Inc's industry is
Biotechnology Research
Zapetite Inc's top competitors are
Penrose Partners,
Salesforce,
Mece Academy,
Biotalent Canada,
Ri-Muhc | Research Institute Of The Muhc | #rimuhc,
Jlc Media,
The Firehood.
Zapetite Inc's categories are Biotechnology Research
Zapetite Inc's founding year is 2024
